MyD88 Adapter-like (Mal)/TIRAP Interaction with TRAF6 Is Critical for TLR2-and TLR4-mediated NF-κB Proinflammatory Responses

被引:172
|
作者
Verstak, Brett [1 ,2 ]
Nagpal, Kamalpreet [3 ]
Bottomley, Stephen P. [4 ]
Golenbock, Douglas T. [3 ]
Hertzog, Paul J. [1 ]
Mansell, Ashley [1 ]
机构
[1] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia
[2] Univ Massachusetts, Sch Med, Cooperat Res Ctr Chron Inflammatory Dis, Worcester, MA 01605 USA
[3] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA 01605 USA
[4] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
关键词
TOLL-LIKE RECEPTORS; SIGNAL-TRANSDUCTION; CUTTING EDGE; TIR-DOMAIN; ACTIVATION; TLR4; MOLECULE; PATHWAY; TRIF; TOLL-LIKE-RECEPTOR-4;
D O I
10.1074/jbc.M109.023044
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll/interleukin-1 (TIR)receptor-containing adapters are critical in orchestrating the different signal transduction pathways following Toll-like receptor (TLR) activation. MyD88 adapter-like (Mal), also termed TIRAP, is involved in bridging MyD88 to the receptor complex for TLR-2 and TLR4 signaling in response to bacterial infection. We have previously reported an interaction between Mal and tumor necrosis factor receptor-associated factor 6 (TRAF6) via a TRAF6-binding motif, the disruption of which inhibited TLR-mediated NF-kappa B-luciferase reporter activity. Given the recent report of intracellular TRAM localization promoting sequential signaling in TLR4 responses, we further characterized Mal interaction with TRAF6, the cellular localization, and the outcomes of disrupting this association on TLR inflammatory responses. We found that Mal and TRAF6 directly interact in response to TLR2 and TLR4 stimulation, although membrane localization is not necessary to facilitate interaction. Critically, reconstitution of murine Mal-deficient macrophages with MalE190A, containing a mutation within the TRAF6-binding motif, fails to reconstitute the proinflammatory response to TLR2 and TLR4 ligands compared with wild type Mal. Furthermore, Mal interaction with TRAF6 mediates Ser phosphorylation of the p65 subunit of NF-kappa B and thus controls transcriptional activation but not nuclear translocation of NF-kappa B. This study characterizes the novel role for Mal in facilitating the direct recruitment of TRAF6 to the plasma membrane, which is necessary for TLR2- and TLR4-induced transactivation of NF-kappa B and regulation of the subsequent pro-inflammatory response.
引用
收藏
页码:24192 / 24203
页数:12
相关论文
共 50 条
  • [41] Adjuvant Efficacy of the ECMS-Oil on Immune Responses against Bordetella bronchiseptica in Mice through the TLR2/MyD88/NF-κB Pathway
    Xiao, Chenwen
    Huang, Yee
    Cui, Xuemei
    Wei, Qiang
    Ji, Quanan
    Liu, Yan
    Fei, Su
    Pan, Yao
    Xu, Xiangfei
    Pan, Huang
    Bao, Guolian
    JOURNAL OF IMMUNOLOGY RESEARCH, 2023, 2023
  • [42] β‐arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4
    Ji Young Kim
    Ji Hye Shin
    Mi-Jeong Kim
    Yeeun Kang
    Ji Su Lee
    Juhee Son
    Soo-Kyung Jeong
    Daesik Kim
    Duk-Hwan Kim
    Eunyoung Chun
    Ki-Young Lee
    Cell Death & Disease, 14
  • [43] Cystatin cures visceral leishmaniasis by NF-κB-mediated proinflammatory response through co-ordination of TLR/MyD88 signaling with p105-Tpl2-ERK pathway
    Kar, Susanta
    Ukil, Anindita
    Das, Pijush K.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (01) : 116 - 127
  • [44] Umbelliferone Alleviates Lipopolysaccharide-Induced Inflammatory Responses in Acute Lung Injury by Down-Regulating TLR4/MyD88/NF-κB Signaling
    Dongqiu Wang
    Xia Wang
    Wen Tong
    Yuhong Cui
    Xiuxian Li
    Haiyun Sun
    Inflammation, 2019, 42 : 440 - 448
  • [45] β-arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4
    Kim, Ji Young
    Shin, Ji Hye
    Kim, Mi-Jeong
    Kang, Yeeun
    Lee, Ji Su
    Son, Juhee
    Jeong, Soo-Kyung
    Kim, Daesik
    Kim, Duk-Hwan
    Chun, Eunyoung
    Lee, Ki-Young
    CELL DEATH & DISEASE, 2023, 14 (07)
  • [46] Glycoprotein from Sargassum fusiforme exhibiting anti-inflammatory responses in vitro and in vivo via modulation of TLR4/MyD88 and NF-κB signaling
    Javed, Ahsan
    Song, Bo-Rim
    Lee, Chang Hyung
    Alam, Md Badrul
    Kim, Solomon L.
    Lee, Sang-Han
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 272
  • [47] Acupuncture Attenuates Inflammation in Microglia of Vascular Dementia Rats by Inhibiting miR-93-Mediated TLR4/MyD88/NF-κB Signaling Pathway
    Wang, Lu
    Yang, Jing-Wen
    Lin, Li-Ting
    Huang, Jin
    Wang, Xue-Rui
    Su, Xin-Tong
    Cao, Yan
    Fisher, Marc
    Liu, Cun-Zhi
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [48] Acupuncture Attenuates Inflammation in Microglia of Vascular Dementia Rats by Inhibiting miR-93-Mediated TLR4/MyD88/NF- κ B Signaling Pathway
    Wang, Lu
    Yang, Jing-Wen
    Lin, Li-Ting
    Huang, Jin
    Wang, Xue-Rui
    Su, Xin-Tong
    Cao, Yan
    Fisher, Marc
    Liu, Cun-Zhi
    Xian, Yanfang
    Liu, Cun-Zhi (lcz623780@126.com), 1600, Hindawi Limited, 410 Park Avenue, 15th Floor, 287 pmb, New York, NY 10022, United States (2020):
  • [49] Bacteroidetes promotes esophageal squamous carcinoma invasion and metastasis through LPS-mediated TLR4/Myd88/NF-κB pathway and inflammatory changes
    Wu, Zhongbing
    Guo, Jianxin
    Zhang, Zhenhan
    Gao, Shuang
    Huang, Ming
    Wang, Yu
    Zhang, Yushuang
    Li, Qinghuan
    Li, Jing
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] Mechanistic Studies of Gypenosides in Microglial State Transition and its Implications in Depression-Like Behaviors: Role of TLR4/MyD88/NF-κB Signaling
    Cao, Li-Hua
    Zhao, Yuan-Yuan
    Bai, Ming
    Geliebter, David
    Geliebter, Jan
    Tiwari, Raj
    He, Hong-Juan
    Wang, Zhen-Zhen
    Jia, Xing-Yuan
    Li, Jin
    Li, Xiu-Min
    Miao, Ming-San
    FRONTIERS IN PHARMACOLOGY, 2022, 13